RAPP · Rapport Therapeutics, Inc.
$47.42
+0.06 (+0.13%)
At close · Aug 14
Market Cap
$2.28B
Shares
47.98M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding RAPP
167 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| SMALLCAP World Fund Inc | — | 3,356,033 | $105,010,273 | 0.13% | Long | 2026-03-31 | |
| Fidelity Growth Company Fund | — | 2,251,968 | $88,952,736 | 0.09% | Long | 2026-05-31 | |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 973,330 | $30,455,496 | 0.00% | Long | 2026-03-31 | |
| Fidelity Growth Company K6 Fund | — | 687,115 | $27,141,043 | 0.10% | Long | 2026-05-31 | |
| Fidelity Series Growth Company Fund | — | 592,106 | $23,388,187 | 0.10% | Long | 2026-05-31 | |
| iShares Russell 2000 ETF | — | 716,935 | $22,432,896 | 0.03% | Long | 2026-03-31 | |
| T. Rowe Price Health Sciences Fund, Inc. | — | 601,105 | $18,808,575 | 0.17% | Long | 2026-03-31 | |
| Select Biotechnology Portfolio | — | 428,273 | $16,916,784 | 0.32% | Long | 2026-05-31 | |
| T. Rowe Price Small-Cap Value Fund, Inc. | — | 364,351 | $11,400,543 | 0.12% | Long | 2026-03-31 | |
| AB Small Cap Growth Portfolio | — | 305,167 | $10,110,183 | 0.35% | Long | 2026-04-30 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 319,366 | $9,992,962 | 0.01% | Long | 2026-03-31 | |
| Fidelity Small Cap Index Fund | — | 290,960 | $9,639,505 | 0.03% | Long | 2026-04-30 | |
| SMALLCAP World Fund Inc | — | 278,547 | $8,715,736 | 0.01% | Long | 2026-03-31 | |
| iShares Russell 2000 Value ETF | — | 252,885 | $7,912,772 | 0.06% | Long | 2026-03-31 | |
| iShares Biotechnology ETF | — | 217,759 | $6,813,679 | 0.08% | Long | 2026-03-31 | |
| VANGUARD RUSSELL 2000 INDEX FUND | — | 151,008 | $5,964,816 | 0.03% | Long | 2026-05-31 | |
| Fidelity Extended Market Index Fund | — | 147,814 | $5,838,653 | 0.01% | Long | 2026-05-31 | |
| Schwab U.S. Small-Cap ETF | — | 138,494 | $5,470,513 | 0.02% | Long | 2026-05-31 | |
| State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF | — | 134,504 | $4,208,630 | 1.37% | Long | 2026-03-31 | |
| Invesco Health Care Fund | — | 109,966 | $3,643,174 | 0.32% | Long | 2026-04-30 | |
| VANGUARD HEALTH CARE INDEX FUND | — | 86,024 | $3,397,948 | 0.02% | Long | 2026-05-31 | |
| SmallCap Growth Fund I | — | 86,494 | $2,865,546 | 0.12% | Long | 2026-04-30 | |
| Dimensional U.S. Small Cap ETF | — | 80,309 | $2,660,637 | 0.02% | Long | 2026-04-30 | |
| VANGUARD U.S. MOMENTUM FACTOR ETF | — | 65,899 | $2,603,011 | 0.14% | Long | 2026-05-31 | |
| iShares U.S. Pharmaceuticals ETF | — | 79,927 | $2,500,916 | 0.25% | Long | 2026-03-31 | |
| U.S. SMALL CAP PORTFOLIO | — | 73,643 | $2,439,793 | 0.01% | Long | 2026-04-30 | |
| iShares Micro-Cap ETF | — | 74,139 | $2,319,809 | 0.19% | Long | 2026-03-31 | |
| Small Cap Core Portfolio | — | 72,340 | $2,263,519 | 0.32% | Long | 2026-03-31 | |
| Avantis U.S. Small Cap Equity ETF | — | 56,640 | $2,237,280 | 0.08% | Long | 2026-05-31 | |
| Schwab Small-Cap Index Fund | — | 64,598 | $2,140,132 | 0.03% | Long | 2026-04-30 | |
| Fidelity Total Market Index Fund | — | 52,725 | $2,082,638 | 0.00% | Long | 2026-05-31 | |
| ALPS Medical Breakthroughs ETF | — | 49,264 | $1,945,928 | 1.20% | Long | 2026-05-31 | |
| U.S. MICRO CAP PORTFOLIO | — | 53,556 | $1,774,310 | 0.02% | Long | 2026-04-30 | |
| Fidelity Series Total Market Index Fund | — | 43,498 | $1,718,171 | 0.00% | Long | 2026-05-31 | |
| Master Small Cap Index Series | — | 44,705 | $1,398,819 | 0.03% | Long | 2026-03-31 | |
| T. Rowe Price Health Sciences Portfolio | — | 37,225 | $1,164,770 | 0.18% | Long | 2026-03-31 | |
| Fidelity Nasdaq Composite Index Fund | — | 28,960 | $1,143,920 | 0.00% | Long | 2026-05-31 | |
| Nuveen Small Cap Blend Index Fund | — | 34,480 | $1,142,322 | 0.03% | Long | 2026-04-30 | |
| Fidelity Small Cap Value Index Fund | — | 36,451 | $1,140,552 | 0.06% | Long | 2026-03-31 | |
| Nuveen Equity Index Fund | — | 33,205 | $1,100,082 | 0.00% | Long | 2026-04-30 | |
| iShares Core S&P Total U.S. Stock Market ETF | — | 32,739 | $1,024,403 | 0.00% | Long | 2026-03-31 | |
| EQ/2000 Managed Volatility Portfolio | — | 30,505 | $954,501 | 0.03% | Long | 2026-03-31 | |
| VANGUARD RUSSELL 2000 VALUE INDEX FUND | — | 23,046 | $910,317 | 0.07% | Long | 2026-05-31 | |
| LVIP State Street Small-Cap Index Fund | — | 21,800 | $908,406 | 0.04% | Long | 2026-06-30 | |
| Goldman Sachs Small Cap Value Insights Fund | — | 25,504 | $844,948 | 0.08% | Long | 2026-04-30 | |
| Schwab U.S. Broad Market ETF | — | 20,394 | $805,563 | 0.00% | Long | 2026-05-31 | |
| AST PGIM Aggressive Multi-Asset Portfolio | — | 21,000 | $657,090 | 0.01% | Long | 2026-03-31 | |
| Bridge Builder Tax Managed Small/Mid Cap Fund | — | 20,043 | $627,145 | 0.02% | Long | 2026-03-31 | |
| Fidelity Nasdaq Composite Index ETF | — | 15,825 | $625,088 | 0.01% | Long | 2026-05-31 | |
| VANGUARD BALANCED INDEX FUND | — | 17,727 | $554,678 | 0.00% | Long | 2026-03-31 |
Showing 1–50 of 167 positions
Key facts
CIK
2012593
CUSIP
75383L102
13F (30d)
156 filings
153 filers
Visit website
Investor relations